Industry

− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM – − Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First … [Read more…]

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort … [Read more…]

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results evaluating VERQUVO® (vericiguat) in adult patients … [Read more…]

– Dr. Aftab has served for over 25 years at Exelixis and has been instrumental in driving the company’s scientific innovation and development activities – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced it has appointed Dana T. Aftab, Ph.D., as its Executive Vice President, Research and Development. In this new role, Dr. Aftab will … [Read more…]

Generative AI technology provides healthcare organizations with stronger protection, clear visibility, and reduced manual oversight SAN FRANCISCO–(BUSINESS WIRE)–#ai–Paubox, the leading provider of HIPAA compliant email security, today unveiled its most ambitious product release to date—Inbound Email Security, the AI-powered inbound email security solution that improves upon rule-based filters with generative artificial intelligence. Phishing attacks remain … [Read more…]

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 9:30 a.m. Eastern Time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The replay will be available … [Read more…]

MADRID–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless of symptoms. The guidelines enable a proactive approach to disease management and underscore that intervention should be considered for asymptomatic patients, regardless of heart function, which is … [Read more…]

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s operations during a fireside chat session at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York. The … [Read more…]

$10,000 Grand Prize goes to the Integrated Roadway Animal Presence and Deterrence System SAN FRANCISCO–(BUSINESS WIRE)–Deepinvent, a Silicon Valley superintelligence company advancing solutions for humanity’s challenges, today revealed the winners of the Deepinvent4Good Inventathon, the world’s first virtual competition empowering innovators to transform bold ideas into meaningful, positive inventions. Out of hundreds of submissions from … [Read more…]

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced that Chief Executive Officer Michael McFadden will present at two prominent healthcare investor conferences this September. Cantor Global Healthcare Conference 2025Date/Time: Friday, September 5, 7:00 a.m. ET H.C. Wainwright & Co. … [Read more…]